Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro

European Respiratory Journal

Volumn 21, Issue 3, 2003, Pages 401-406

  Tsang, K W ^a   Ng, P ^a   Ho, P L ^a   Chan, S ^a   Tipoe, G ^a   Leung, R ^a   Sun, J ^a   Ho, J C ^a   Ip, M S ^a   Lam, W K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bacterial adherence; Bacterial morphology; Erythromycin; Pseudomonas aeruginosa; Subminimal inhibitory concentration

Indexed keywords

COLLAGEN TYPE 4; ERYTHROMYCIN;

AIRWAY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BASEMENT MEMBRANE; CONTROLLED STUDY; DENSITY; DRUG EFFICACY; GRAM NEGATIVE INFECTION; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LOW DRUG DOSE; MICROMORPHOLOGY; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZATION; SCANNING ELECTRON MICROSCOPY;

EID: 0037341995     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00050903     Document Type: Article

References (32)

1. Pitt TL. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J Royal Soc Med 1986; 79: Suppl. 12, 13-18.
2. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989; 180: 487-502.
3. Madri JA, Furthmayr H. Collagen polymorphism in the lung: an immunochemical study of pulmonary fibrosis. Hum Pathol 1980; 11: 353-366.
4. Baltimore RS, Christie CDC, Walker-Smith GJ. Immunohistological localisation of Pseudomonas aeruginosa in lungs of patients with cystic fibrosis. Am Rev Respir Dis 1989; 140: 1650-1661.
5. Tsang KW, Rutman A, Dewar A, et al. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J 1994; 7: 1746-1753.
6. Kubesch P, Lingner M, Grothues D, Wehsling M, Tummler B. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung. Scand J Gastroenterol 1988; 23: Suppl. 143, 77-80.
7. Kudoh S, Uetake T, Hagiwara K, et al. Clinical effects of low-dose, long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987; 25: 632-642.
8. Iwata M, Sata A, Colby T. Diffuse panbronchiolitis. In: Epler GR, ed. Diseases of the Bronchioles. New York, Raven Press, 1994; pp. 153-179.
9. Tsang KWT, Ooi C, Tanaka E, et al. Diffuse panbronchiolitis in Chinese patients. Thorax 1998; 53: 274-280.
10. Fujii T, Kadota JI, Kawakami K, et al. Long term effect of erythromycin therapy in patients with chronic Pseudmonas aeruginosa infection. Thorax 1995; 50: 1246-1252.
11. Tsang KW, Ho PL, Ip M, et al. The effects of low dose erythromycin in bronchiectasis: a pilot study. Eur Respir J 1999; 13: 361-364.
12. Stout SA, Derendorf H. Local treatment of respiratory infections with antibiotics. DICP 1987; 21: 322-329.
13. Bergogne-Berezin E. Pharmacokinetics of antibiotics in respiratory secretions. In: Pennington JE, ed. Respiratory infections: Diagnosis and Management. 2nd edn. New York, Raven Press, 1988; pp. 608-631.
14. Marlin GE, Davis PR, Rutland J, Berend N. Plasma and sputum erythromycin concentrations in chronic bronchitis. Thorax 1980; 35: 441-445.
15. Tanaka E, Kanthakumar K, Cundell DR, et al. The effects of erythromycin on Pseudomonas aeruginosa and neutrophil mediated damage. J Antimicrob Chemother 1994; 33: 765-775.
16. Vishwanath S, Guay CM, Ramphal R. Effects of subminimal inhibitory concentrations of antibiotics on the adherence of Pseudomonas aeruginosa to tracheobronchial mucin. J Antimicrob Chemother 1987; 19: 579-583.
17. Tsang KW, Chan SL, Ng PW, Ip MS, Lam WK. Adherence of Pseudomonas aeruginosa to basement membrane collagen in vitro. Am J Respir Crit Care Med 1999; 159: Suppl. 2, A307.
18. Goswami SK, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 1990; 141: 72-78.
19. Marom ZM, Goswami SK. Respiratory mucus hypersecretion (bronchorrhea): a case discussion - possible mechanism(s) and treatment. J Allergy Clin Immunol 1991; 87: 1050-1055.
20. Koh YY, Lee MH, Sun YH, Sung KW, Chae JH. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J 1997; 10: 994-999.
21. Chopra I, Linton A. The antibiotic effects of low concentrations of antibiotics. Adv Microb Physiol 1986; 28: 211-215.
22. Lorian V, Atkinson B. Abnormal forms of bacteria produced by antibiotics. Am J Clin Pathol 1975; 64: 678-688.
23. Yamasaki T, Ichimiya T, Hirai K, Hiramatsu K, Nasu M. Effect of antimicrobial agents on the piliation of Pseudomonas aeruginosa and adherence to mouse tracheal epithelium. J Chemother 1997; 9: 32-37.
24. Tanaka E, Kanthakumar K, Cundell DR, et al. The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage. J Antimicrob Chemother 1994; 33: 765-775.
25. Sofer D, Gilboa-Garber N, Belz A, Garber NC. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 1999; 45: 335-341.
26. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and auto-oxidation. J Infect Dis 1989; 159: 966-973.
27. Ichimiya T, Yamasaki T, Nasu M. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother 1994; 34: 331-341.
28. Chan EL, Harris RC, Dalton HP. The effect of antibiotics on the cell morphology of Legionella pneumophila. J Med Microbiol 1987; 23: 149-154.
29. Lorian V, Ernst J. Effects of antibiotics on bacterial structure and their pathogenicity. Pathol Biol 1987; 35: 1370-1376.
30. Braga PC, Piatti G. Sub-lethal concentrations of clarithromycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells. J Chemother 1993; 5: 159-163.
31. Beachey EH. Bacterial adherence: adhesin receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis 1981; 143: 325-345.
32. Govan JRW, Harris GS. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol Sci 1986; 3: 302-308.